Sort
48,018 grants matching “immunotherapy”
Enhancing immune mediated head and neck cancer anti-tumor activity using nanoparticles
$518,603Sunil Krishnan · Mayo Clinic Jacksonville · R01 · FY2020 · DE
Localized immunotherapy using alum-binding therapeutics
$518,397Darrell J Irvine · Massachusetts Institute Of Technology · R01 · FY2023 · EB
Deciphering the Molecular Mechanisms Underlying Cholangiocarcinoma Development
$518,219Sungjin Ko · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
PHASE I/II TRIAL OF HOKT3(1(ALA-ALA) IN TYPE 1 DIABETES
$518,215Columbia University Health Sciences · R01 · FY2000 · DK
A New Immune Checkpoint Pathway in Human Bladder Cancer
$518,205Xingxing Zang · Albert Einstein College Of Medicine · R01 · FY2024 · CA
Immunotherapy of B cell lymphoma with NK-T cells
$518,190Leonid S Metelitsa · Baylor College Of Medicine · P50 · FY2020 · CA
Targeting posttranslational modifications of B7-H4 in carcinogenesis and therapy
$518,180Yong Wan · Emory University · R01 · FY2022 · CA
(PQ3) The role of damaged DNA in inter-individual variation of tumor immunity
$518,165Nir Hacohen · Broad Institute, Inc. · R01 · FY2020 · CA
(PQ3) The role of damaged DNA in inter-individual variation of tumor immunity
$518,165Nir Hacohen · Broad Institute, Inc. · R01 · FY2017 · CA
(PQ3) The role of damaged DNA in inter-individual variation of tumor immunity
$518,165Nir Hacohen · Broad Institute, Inc. · R01 · FY2016 · CA
(PQ3) The role of damaged DNA in inter-individual variation of tumor immunity
$518,165Nir Hacohen · Broad Institute, Inc. · R01 · FY2018 · CA
Training In Cell and Gene Therapy
$518,127Helen E Heslop · Baylor College Of Medicine · T32 · FY2025 · HL
Molecular mechanisms of T cell responses to a clonal neoantigen resulting from a mutated driver oncogene.
$518,107Christopher Austin Klebanoff · Sloan-Kettering Inst Can Research · R37 · FY2023 · CA
Dysregulated mechanoimmunology of epigenetics-driven lymphomas
$518,073Ankur Singh · Georgia Institute Of Technology · U01 · FY2025 · CA
Project 3: Dynamics of Immune Signatures and Microbiome in Patients with Cervical Pre-Cancer and Cancer Among Women.
$518,029Vijayakumar Velu · University Of Miami School Of Medicine · U54 · FY2025 · CA
Developing Tolerance Approaches to Overcome Humoral Immunity
$517,958Stuart Johnston Knechtle · Emory University · U19 · FY2015 · AI
Imaging-guided fine tuning of CAR T cell affinity to limit T cell cytotoxicity to tumor antigen
$517,929Moonsoo M. Jin · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · CA
Mechanisms of Hepatitis C Virus Evolution
$517,928Stuart C Ray · Johns Hopkins University · R01 · FY2009 · DA
Project 2: Targeting differentiation-linked redox sensitivity in melanoma
$517,922Thomas G Graeber · University Of California Los Angeles · P01 · FY2021 · CA
Project 2: Targeting differentiation-linked redox sensitivity in melanoma
$517,922Thomas G Graeber · University Of California Los Angeles · P01 · FY2020 · CA
Project 3: Modeling and overcoming resistance to melanoma immunotherapy
$517,920Antoni Ribas · University Of California Los Angeles · P01 · FY2021 · CA
Project 1: Strategies to enhance MEK inhibitor efficacy in MUTNRAS melanoma
$517,920Roger S Lo · University Of California Los Angeles · P01 · FY2020 · CA
Project 1: Strategies to enhance MEK inhibitor efficacy in MUTNRAS melanoma
$517,920Roger S Lo · University Of California Los Angeles · P01 · FY2021 · CA
Project 3: Modeling and overcoming resistance to melanoma immunotherapy
$517,920Antoni Ribas · University Of California Los Angeles · P01 · FY2020 · CA
Mechanisms of Hepatitis C Virus Evolution
$517,865Stuart C Ray · Johns Hopkins University · R01 · FY2007 · DA